News

The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.

Read more

If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Read more

If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Read more

This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.

Read more

This finding among sub-Saharan Africans is quite concerning since dolutegravir is now the preferred first-line HIV treatment worldwide.

Read more

ViiV Healthcare teams with stock photography provider Shutterstock to offer a stigma-busting gallery of images.

Read more

The vaccine, which is safe, was designed using bits of an HIV protein.

Read more

Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.

Read more

The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.

Read more

While receiving a lifetime achievement award, the infectious disease expert shares memories and insights.

Read more

Plus: Seven European cities surpass the Fast-Track HIV targets.

Read more

UNAIDS hopes nations will follow the lead of a number of sub-Saharan African countries that are gaining control of their HIV epidemics.

Read more

Subcategories